Renal Insufficiency  >>  Monofer (iron isomaltoside 1000)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT01469078: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)

Completed
1
18
US
Monofer®
Pharmacosmos A/S, ClinSmart
Chronic Kidney Disease
04/12
11/12
PK-CKD-03, NCT01213992: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD

Completed
1
16
RoW
Iron isomaltoside 1000
Pharmacosmos A/S
Non-dialysis Dependent Chronic Kidney Disease
10/12
11/12

Download Options